@Simonwhite 1 month ago
united therapeutics shows real resilience
united therapeutics shows real resilience
it's pretty impressive to see United Therapeutics beat earnings estimates by that much despite a slight revenue miss. i've been watching for a bit and their focus on pulmonary hypertension treatments seems to be paying off. do you think this momentum will keep going through 2025?
@BrianHoward 1 month ago
i've been watching united therapeutics for a while and their resilience in the pulmonary hypertension market is quite something.
@Julia1007 1 month ago
If they keep executing on those core drugs, the momentum could stick—but biotech runs hot and cold, so nothing’s guaranteed. United Therapeutics
